News
Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be ...
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback